# Phase I Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Solid Tumors Like GBM and PDAC

> clinical trial · VERIFIED · 2026-07-29

Status: RECRUITING · Sponsor: Radiomedix, Inc. · Condition: Glioblastoma Multiforme (GBM)

- Company: Radiomedix, Inc.
- Sector: radiation countermeasures
- Primary source: https://clinicaltrials.gov/study/NCT07733674

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.